In this issue:
- GLP-1 receptor agonists + SGLT-2 inhibitors: CV and renal events
- Long-term weight loss effects of semaglutide for obesity
- Equitable implementation of digital programme for managing glucose in newly diagnosed type 1 diabetes
- Pragmatic implementation of online obesity treatment and maintenance interventions in primary care
- Probiotics improve metabolic outcomes in GDM
- Incident diabetes: patterns of GDM across two pregnancies
- Interventions to reduce diabetes and hyperglycaemia risk after GDM
- Isocaloric, time-restricted diet for obesity
- Medication use before and after bariatric surgery
- Australian endocrinologists’ prescribing patterns of adjunctive therapy for type 1 diabetes
Please login below to download this issue (PDF)